Compare Tempus AI (TEM) vs Wynn Resorts, Limited (WYNN) Price & Performance

Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.

The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.

Wynn Resorts (WYNN) trades at $74.97, down 2.15% today, with a bearish technical signal despite bullish oscillators. The company reported mixed Q2 2026 results, beating EPS estimates but facing margin pressures. Revenue reached $7.14B in 2025, though net income declined to $327M. Analysts maintain a strong buy consensus with a $132.36 price target, while institutional activity shows mixed positioning amid high debt levels and significant capital expenditure plans.

The outlook for WYNN hinges on Macau recovery and successful execution of UAE expansion, but rising capex and debt servicing costs pose risks. Current valuation metrics appear reasonable with P/E of 18.06 and EV/EBITDA of 9.23, though investors should monitor margin trends and project timelines closely given the stock's significant discount to analyst targets.